Clinically relevant analysis showed that patients aged young, with small tumor size and adenocarcinoma, in low tumor stage, as well as without lymph node metastasis had higher GAS5 levels and lower miR‐21 levels (Table 2). This evidence concerns the gene GAS5 and adenocarcinoma.